I told ya - the inequitable conduct argument is the best argument ,IMHO they have even after the recent en banc opinion
I am betting they are going to win this case. pre-2014 launch was one of the reasons(of course I am happy with other alternative - 2014 copaxone launch)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.